Department of Pharmaceutical Chemistry, Institute of Health Biosciences, Graduate School of The University of Tokushima, Tokushima, Japan.
Bioorg Med Chem Lett. 2012 Oct 15;22(20):6425-8. doi: 10.1016/j.bmcl.2012.08.057. Epub 2012 Aug 23.
Three water-soluble fibrates (fenofibrate, bezafibrate and chlofibrate) conjugated with a symmetrically branched glyceryl trimer (BGL003) were synthesized, and an evaluation of the fenofibrate-BGL003 conjugate as a candidate for anti-hyperlipemia drug was carried out using rats. The water-solubility of the fenofibrate-BGL003 conjugate was several thousand times greater than that of the original fenofibrate. The lipid-lowering effects of the fenofibrate-BGL003 conjugate were as strong as those of the same grams of fenofibrate. The actual active species of fenofibrate, fenofibric acid, was detected in rats' blood, but neither the fenofibrate-BGL003 conjugate nor fenofibrate was detected, probably due to enzymatic hydrolysis of the ester bond. The plasma concentration of fenofibric acid derived from the fenofibrate-BGL003 conjugate was five times higher than that derived from fenofibrate 4h after administration.
合成了三种水溶性纤维酸酯(非诺贝特、苯扎贝特和氯贝特)与对称支化甘油三酯(BGL003)的缀合物,并使用大鼠对非诺贝特-BGL003 缀合物作为抗高脂血症药物候选物进行了评估。非诺贝特-BGL003 缀合物的水溶性比原始非诺贝特高几千倍。非诺贝特-BGL003 缀合物的降血脂作用与相同克数的非诺贝特一样强。在大鼠血液中检测到了非诺贝特的实际活性物质非诺贝特酸,但未检测到非诺贝特-BGL003 缀合物或非诺贝特,这可能是由于酯键的酶水解。非诺贝特-BGL003 缀合物衍生的非诺贝特酸的血浆浓度在给药后 4 小时是源自非诺贝特的五倍。